Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.700
+0.080 (3.05%)
Feb 27, 2026, 4:00 PM EST - Market closed
Nkarta Market Cap
Nkarta has a market cap or net worth of $191.78 million as of February 27, 2026. Its market cap has increased by 31.29% in one year.
Market Cap
191.78M
Enterprise Value
-13.92M
1-Year Change
31.29%
Ranking
Category
Stock Price
$2.70
Market Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $191.78M, a decrease of -86.90%. That is a compound annual growth rate of -30.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 191.78M | 45.95% |
| Dec 31, 2025 | 131.40M | -25.22% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Canton Strategic Holdings | 200.42M |
| NeOnc Technologies Holdings | 199.03M |
| Cartesian Therapeutics | 197.37M |
| Kalaris Therapeutics | 195.63M |
| SAB Biotherapeutics | 195.19M |
| Galectin Therapeutics | 192.13M |
| Acumen Pharmaceuticals | 190.20M |
| Molecular Partners AG | 188.23M |